**ADT Candidate - Debiopharm** is not a medical condition itself, but refers to a potential new medication or therapy being developed by the company Debiopharm. This development is focused on improving **Androgen Deprivation Therapy (ADT)**. ADT is a common treatment for certain conditions, primarily prostate cancer, aiming to reduce male hormones that can fuel cancer growth. New ADT candidates seek to enhance treatment effectiveness or reduce side effects for patients.
Please review the videos and resources below at your own pace.
Recommended Resources
1-3 of 3
Related Resources from Carolina Urologic Research Center
0-0 of 0
Meet Carolina Urologic Research Center
Locations
Carolina Urologic Research Center (CURC), is a separate and independent research arm of Grand Strand Urology, a division of Atlantic Urology Clinics in Myrtle Beach, SC. Under the direction of Dr. Neal Shore, CURC conducts phase I – IV drug, biotechnology and device trials focusing on urological diseases. CURC has been recognized both nationally & internationally as one of the most progressive, well-organized, and respected clinical research sites in the United States.
